(Q3)May 31, 2024 | (Q2)Feb 29, 2024 | (Q1)Nov 30, 2023 | (FY)Aug 31, 2023 | (Q4)Aug 31, 2023 | (Q3)May 31, 2023 | (Q2)Feb 28, 2023 | (Q1)Nov 30, 2022 | |
---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||
Cash flow from continuing operating activities | 78.16%-139.76K | 71.99%-160.06K | -100.23%-244.43K | -1.69M | -358.52K | -639.97K | -571.54K | -122.07K |
Net income from continuing operations | 70.87%-398.66K | 57.96%-531.33K | -13.11%-419.92K | ---8.15M | ---4.92M | ---1.37M | ---1.26M | ---371.25K |
Operating gains losses | --147.16K | --141.95K | --63.98K | --57.9K | ---- | ---- | ---- | ---- |
Depreciation and amortization | -99.77%963 | -99.87%545 | -96.73%454 | --1.39M | --417.12K | --417.57K | --416.67K | --13.89K |
Asset impairment expenditure | ---- | ---- | ---- | --3.61M | ---- | ---- | ---- | ---- |
Remuneration paid in stock | -92.36%27.98K | -49.22%207.2K | -24.90%152.94K | --1.3M | --218.59K | --366.29K | --407.99K | --203.66K |
Change In working capital | 250.18%82.8K | 116.32%21.58K | -232.42%-41.89K | --104.59K | --260.29K | ---55.13K | ---132.2K | --31.63K |
-Change in receivables | 554.42%44.06K | -429.25%-56.68K | -306.88%-11.53K | ---24.05K | ---805 | ---9.7K | ---10.71K | ---2.83K |
-Change in prepaid assets | 50.52%-5.28K | 63.99%-623 | 99.30%-292 | ---33.73K | --20.17K | ---10.68K | ---1.73K | ---41.49K |
-Change in payables and accrued expense | 12.79%42.79K | 81.05%65.37K | -138.34%-29.12K | --152.59K | --2.6K | --37.93K | --36.11K | --75.95K |
-Change in other working capital | 101.69%1.23K | 108.67%13.52K | ---940 | --9.77K | --238.32K | ---72.69K | ---155.87K | ---- |
Cash from discontinued investing activities | ||||||||
Operating cash flow | 78.16%-139.76K | 71.99%-160.06K | -100.23%-244.43K | ---1.69M | ---358.52K | ---639.97K | ---571.54K | ---122.07K |
Investing cash flow | ||||||||
Cash flow from continuing investing activities | -6.54K | 0 | ||||||
Net PPE purchase and sale | ---- | ---- | ---- | ---6.54K | --0 | ---- | ---- | ---- |
Cash from discontinued investing activities | ||||||||
Investing cash flow | ---- | ---- | ---- | ---6.54K | --0 | --0 | ---- | ---- |
Financing cash flow | ||||||||
Cash flow from continuing financing activities | -22.80%146.53K | 110.28K | -97.44%42.41K | 1.98M | 132.65K | 189.8K | 0 | 1.66M |
Net common stock issuance | --0 | --0 | --0 | --1.66M | --0 | --0 | --0 | --1.66M |
Proceeds from stock option exercised by employees | 166.41%146.53K | --110.28K | --42.41K | --322.46K | --132.65K | --55K | ---- | --0 |
Net other financing activities | ---- | ---- | ---- | ---- | ---- | --134.8K | ---- | ---- |
Cash from discontinued financing activities | ||||||||
Financing cash flow | -22.80%146.53K | --110.28K | -97.44%42.41K | --1.98M | --132.65K | --189.8K | --0 | --1.66M |
Net cash flow | ||||||||
Beginning cash position | -96.93%29.38K | -94.84%79.16K | 28,117,100.00%281.17K | --1 | --507.04K | --957.2K | --1.54M | --1 |
Current changes in cash | 101.50%6.77K | 91.29%-49.78K | -113.16%-202.01K | --281.17K | ---225.87K | ---450.16K | ---571.54K | --1.54M |
Effect of exchange rate changes | ---- | ---- | ---- | ---- | ---- | --0 | ---6.54K | ---- |
End cash Position | -92.87%36.15K | -96.93%29.38K | -94.84%79.16K | --281.17K | --281.17K | --507.04K | --957.2K | --1.54M |
Free cash from | 78.16%-139.76K | 71.99%-160.06K | -100.23%-244.43K | ---1.7M | ---358.52K | ---639.97K | ---571.54K | ---122.07K |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.